Target intelligence / Profile preview

Skin barrier function (stratum corneum lipid organization)

Molecular classification
Other (structural and physiological barrier, primarily composed of lipids—ceramides, cholesterol, fatty acids—in stratum corneum; not a receptor, enzyme, transporter, etc.)
01

Overview

“Skin barrier function enhancement via increased permeability” describes the process and impact of increasing the skin’s transdermal permeability, most often achieved by chemical permeation enhancers. The main physical barrier to permeation is the lipid-rich stratum corneum; chemicals like DMSO and propylene glycol disrupt the ordered structure of its lipid bilayers (principally ceramides, cholesterol, fatty acids), inducing a transition from a rigid gel phase to a liquid-crystalline, more permeable state. This increases the rate and extent of drug, water, and other molecule transport across the skin but may be associated with safety risks due to diminished protection against water loss, pathogens, allergens, and irritants.

Other names
Skin permeability barrierStratum corneum barrierEpidermal barrier function
02

Mechanism of action

Disruption or fluidization of stratum corneum lipid organization, usually by phase transition from gel-like to liquid-crystalline arrangement to increase permeability; Extraction or rearrangement of cholesterol and other lipid components; Partition into lipid layers and transient perturbation of lipid order

03

Biological functions

Regulation of transdermal permeationProtection against dehydrationPrevention of pathogen entryImmune function modulation
04

Disease associations

DermatitisPsoriasisAtopic eczemaInfection (e.g., increased permeability can lead to susceptibility to pathogens)Other (impaired barrier involved in numerous skin diseases)
05

Safety considerations

Skin irritationAllergic reactionsBarrier compromise leading to dehydration, infection, or sensitizationPotential for increased absorption of toxins or allergensChronic use may worsen inflammatory skin diseases
06

Interacting drugs

Dimethyl sulfoxide (DMSO)

10 more in the full profile.

07

Biomarkers

Transepidermal water loss (TEWL; indicator of barrier compromise or permeability)Ceramide content/composition in stratum corneum

Beyond the preview

Go deeper on Skin barrier function (stratum corneum lipid organization).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Skin barrier function (stratum corneum lipid organization).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call